Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Open to Debate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Open to Debate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Prescription Weight Loss Drugs for All?

53:15
 
Share
 

Manage episode 462931842 series 2140049
Content provided by Open to Debate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Open to Debate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have opened doors for people to lose weight. Should everyone have the option to take it? Those arguing “yes” say obesity needs to be treated using every available tool, especially for people for whom diet, lifestyle changes, and exercise aren’t enough. Those arguing “no” are concerned about its side effects and the risks if people don’t take them as directed. Now we debate: should prescription weight loss drugs be available for all?

Arguing Yes: David Allison, Obesity Researcher; Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington

Arguing No: Stuart W. Flint, Associate Professor of the Psychology of Obesity at the University of Leeds

Emmy award-winning journalist John Donvan moderates

Learn more about your ad choices. Visit podcastchoices.com/adchoices

  continue reading

424 episodes

Artwork

Prescription Weight Loss Drugs for All?

Open to Debate

282 subscribers

published

iconShare
 
Manage episode 462931842 series 2140049
Content provided by Open to Debate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Open to Debate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have opened doors for people to lose weight. Should everyone have the option to take it? Those arguing “yes” say obesity needs to be treated using every available tool, especially for people for whom diet, lifestyle changes, and exercise aren’t enough. Those arguing “no” are concerned about its side effects and the risks if people don’t take them as directed. Now we debate: should prescription weight loss drugs be available for all?

Arguing Yes: David Allison, Obesity Researcher; Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington

Arguing No: Stuart W. Flint, Associate Professor of the Psychology of Obesity at the University of Leeds

Emmy award-winning journalist John Donvan moderates

Learn more about your ad choices. Visit podcastchoices.com/adchoices

  continue reading

424 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play